realme V13上手：定位千元机，7nm芯片-中关村在线头条 zol.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zol.com.cn Daily Mail and Mail on Sunday newspapers.
BH Macro Limited - Net Asset Value(s)
PR Newswire
(a closed-ended investment company incorporated in Guernsey with registration number 46235)
LEI: 549300ZOFF0Z2CM87C29
Announcement of Weekly Estimated Net Asset Values
As at the close of business on 9th April 2021 the estimated Net Asset Values of each class of the Company s shares are as follows:
Fund Name
9th April 2021
The Net Asset Value figures in this announcement are an estimate, and are based on unaudited estimated valuations. The final month-end Net Asset Value may be materially different from these estimated weekly values, and should only be taken as indicative values which have been provided for information only and no reliance should be placed on them. Estimated results, performance or achievements may differ materially from any actual results, performance or achievements. Except as required by applicable law, the Company expressly disclaims any obligations to update or revise such estimates to reflect any change
BH Macro Limited - Net Asset Value(s) PR Newswire London, March 16 BH MACRO LIMITED (the "Company") (a closed-ended investment company incorporated in Guernsey with
Message :
Required fields
Buenos Aires, Argentina, March 10, 2021 - Banco Macro S.A. (NYSE: BMA; BYMA: BMA) ( Banco Macro or BMA or the Bank ) announced today its results for the fourth quarter ended December 31, 2020 ( 4Q20 ). All figures are in Argentine pesos (Ps.) and have been restated in terms of the measuring unit current at the end of the reporting period. As of January 2020, the Bank began reporting results applying Hyperinflation Accounting, in accordance with IFRS IAS 29 as established by the Central Bank. For ease of comparison, figures of previous quarters of 2019 and 2020 have been restated applying IAS 29 to reflect the accumulated effect of the inflation adjustment for each period through December 31, 2020.
When every moment matters, laboratories are asked to rapidly convey test results enabling prompt reactions. Acura®
electro micropipettes bring fast and reliable results with excellent ergonomics.
During the past year, research activities were mainly focussed on COVID related topics to better understand and monitor current pandemic. Pharma and biotech sectors concentrated strength on creating appropriate vaccines, while clinical field tested patients to monitor infection level within population.
To meet the needs for urgent results, the Socorex Acura®
electro micro-, macro- and multichannel pipettes are the perfect dosing instruments to work with. The assortment includes eleven single channel models ranging from 0.1 µL to 10 mL, while four models with 8 and 12 channels cover the volume range from 0.5 µL to 350 µL. The line offers shape, balance and working ergonomics resembling those of a manual instrument. But comfort is so greatly improved that pipetting and result consi